AKTS news

Latest 1 stories · newest Nov 12, 2026

AKTS

Aktis Oncology Starts Phase 1b Trial for AKY-2519

Aktis Oncology initiated its third Phase 1b clinical trial of AKY-2519 to treat lung cancer, expanding its portfolio of targeted radiopharmaceuticals. The update reflects the company's ongoing progress in clinical development.

Other Nov 12, 2026 sentiment +0.40 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same AKTS feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/AKTS/newsSTART FREE